BMI Influences Prognosis Following Surgery and Adjuvant Chemotherapy for Lymph Node Positive Breast Cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Breast Journal

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4741.2008.00598.xPMID 18540954PMCID PMC4906544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients

  2005cited by this paper
• Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

  2003cited by this paper
• Waist-to-hip ratio and breast cancer mortality.

  2003cited by this paper
• Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

  2002cited by this paper
• Long-Term Follow-Up of a Phase II Trial Studying a Weekly Doxorubicin-Based Multiple Drug Adjuvant Therapy for Stage II Node-Positive Carcinoma of the Breast

  2002cited by this paper
• Weight loss in breast cancer patient management.

  2002cited by this paper
• Is body mass index the prognostic factor in breast cancer?: a meta-analysis.

  2001cited by this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cited by this paper
• The breast

  1999cited by this paper
• The effect of dietary exposures on recurrence and mortality in early stage breast cancer

  1998cited by this paper
• Social class and weight as prognostic factors in early breast cancer.

  1997cited by this paper
• The effect of body mass index and oestrogen receptor level on survival of breast cancer patients.

  1997cited by this paper
• Survival of women with node negative breast cancer in the Auckland region.

  1996cited by this paper
• Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.

  1995cited by this paper
• Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project

  1995cited by this paper
• Pre‐morbid body size and the prognosis of women with breast cancer

  1994cited by this paper
• Endogenous hormones and breast cancer risk.

  1993cited by this paper
• Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women.

  1991cited by this paper
• Martingale-based residuals for survival models

  1990cited by this paper
• Sex Hormone Binding Globulin: Origin, Function and Clinical Significance

  1990cited by this paper
• Body size and breast cancer prognosis: A critical review of the evidence

  1990cited by this paper
• Obesity as prognostic factors in breast cancer.

  1990cited by this paper
• Body size and breast cancer prognosis: a statistical explanation of the discrepancies.

  1989cited by this paper
• Risk factors and 10-year breast cancer survival in Northern Alberta

  1989cited by this paper
• Adipose tissue as a source of hormones.

  1987cited by this paper
• Body weight and prognosis in breast cancer.

  1981cited by this paper
• Cholesterol and obesity as prognostic factors in breast cancer

  1981cited by this paper
• The association of body weight with recurrent cancer of the breast

  1978cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The impact of fat graft reconstructive surgery on prognosis in young women with breast cancer: a study from the French insurance databases.

  2025cites this paper
• The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

  2024cites this paper
• Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis

  2022cites this paper
• Body Mass Index and Clinical Outcomes in Egyptian Women with Breast Cancer: A Multi-institutional Study

  2020cites this paper
• Immediate Breast Reconstruction in Pregnancy and Lactation

  2019cites this paper
• Obesity and mortality after locoregional breast cancer diagnosis

  2018cites this paper
• The Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.

  2017cites this paper
• Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival

  2015cites this paper
• The effect of obesity on recurrence pattern in early breast cancer patients.

  2015cites this paper
• Anesthetic Choices and Breast Cancer Recurrence: A Retrospective Pilot Study of Patient, Disease, and Treatment Factors

  2015cites this paper
• Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases.

  2015cites this paper
• Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.

  2014cites this paper
• Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies

  2014cites this paper
• Clinical Medicine Insights : Women ’ s Health Weight Loss Intervention in Survivors of ER / PR-negative Breast Cancer

  2014cites this paper
• Body Mass Index PredictsStroke Prognosis

  2013cites this paper
• Executing and teaching science---The breast cancer genetics and technology-rich curriculum professional development studies of a science educator

  2013influential citation
• Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

  2012cites this paper
• Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.

  2012cites this paper
• Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis

  2012cites this paper
• Impact of a Raised Body Mass Index on Breast Cancer Survival in Relation to Age and Disease Extent at Diagnosis

  2010cites this paper
• Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

  2010cites this paper
• The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

  2009cites this paper
• Impact de l’alimentation sur le pronostic du cancer du sein

  2009cites this paper